Market Trends of Single-Use Assemblies Industry
Biopharmaceutical and Pharmaceutical Companies Segment Accounted For Significant Market Share
- Biopharmaceutical companies utilize a single-use system to manufacture the final product by using large-scale single-use assemblies. It allows process components or lines to be disposed of when a project has been completed instead of cleaning and sterilizing stainless steel or glass equipment. Such advantages drive the pharmaceutical and bio-pharmaceutical sectors to adopt single-use assemblies.
- In addition, the increased burden of chronic diseases and a higher need for advanced therapeutics prompted pharmaceutical and biopharmaceutical companies to expand their manufacturing capabilities, which, in turn, is projected to foster the demand for single-use assemblies.
- For instance, in April 2024, Aptar Pharma announced a capacity expansion plan in North America at its Aptar Congers, New York site. Aptar Pharma is significantly expanding the manufacturing capacity of its proprietary Unidose (UDS) Nasal Spray Systems via the addition of molds and assembly lines in cleanroom manufacturing settings and the installation of an assembly line to expand further the manufacturing of its bag-on-vale (BOV) technology. This expansion is anticipated to drive the application of single-use bottle assemblies, which is, in turn, expected to accelerate segmental market growth during the forecast period.
- Similarly, in January 2024, AbbVie Inc. invested USD 223 million to expand Singapore's Tuas Biomedical Park manufacturing facility. The investment is anticipated to add more than 100 jobs and new biologics manufacturing capacity to AbbVie's global network and promote the application of single-use systems and assemblies.
- Therefore, factors such as the rising adoption of single-use assemblies in biopharmaceutical companies and rising investments from key market players are expected to drive the growth of the biopharmaceutical and pharmaceutical companies segment during the forecast period.
Understand The Key Trends Shaping This Market
Download PDF
North America is Expected to Witness Significant Growth Opportunities Over the Study Period
- The factors responsible for the significant market in North America include the well-established biopharmaceutical sector, widespread availability of single-use assemblies supplied by regional market leaders, and rising biologics and biosimilar manufacturing.
- The increasing investments in biopharmaceutical sectors by pharmaceutical companies and public organizations are expected to foster the demand for single-use assemblies to reduce cross-contamination and promote cost-effective manufacturing. For instance, according to the fact sheet released in September 2022 by the Department of Health and Human Services, the government planned to invest USD 40 million to expand the role of biomanufacturing in active pharmaceutical ingredients (APIs), antibiotics, and the critical starting materials to produce essential medications and respond to pandemics. Thus, such investment activities in the region are likely to accelerate the adoption of single-use assemblies over the study period.
- Similarly, in June 2023, the government of Canada invested more than USD 2.1 billion in 36 projects in the biomanufacturing, vaccine, and therapeutics ecosystem across the country. Thus, such investment in biomanufacturing is likely to create a high demand for single-use assemblies in the region, as the single-use technologies can lower turn-around costs by reducing or eliminating the need for expensive stainless-steel equipment and the associated expenses of installation and cleaning, which ultimately expected to fuel the regional market growth over the forecast period.
- Moreover, the presence of several key players in the region and strategic initiatives undertaken by them are further projected to accelerate regional market expansion. For instance, in November 2022, Cardinal Health expanded its single-use device reprocessing facility in Riverview, Florida, with a capacity of 100,000 sq. ft. In addition, in August 2022, Thermo Fisher Scientific Inc. opened one of the largest single-use technology manufacturing sites in Greater Nashville. An investment of USD 105 million in the facility adds capacity to enable more life-saving vaccines and therapies. Thus, such initiatives undertaken by market players are projected to foster industry expansion over the study period.
- Thus, owing to the above-mentioned factors, such as increasing demand for single-use assemblies, growing investments in the biopharmaceutical sector, and several strategic initiatives undertaken by industry participants, market growth in North America is expected to accelerate during the study period.
Get Analysis on Important Geographic Markets
Download PDF
